Cargando…
Managing Opioid Withdrawal in an Outpatient Setting With Lofexidine or Clonidine
Background There is a need for improved strategies for managing abrupt opioid withdrawal when transitioning patients with opioid use disorder to comprehensive longitudinal care strategies such as naltrexone maintenance treatment. In addition, alpha-2 adrenergic agonists are used to ameliorate withdr...
Autores principales: | Gripshover, Jeanne, Kosten, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437420/ https://www.ncbi.nlm.nih.gov/pubmed/36072176 http://dx.doi.org/10.7759/cureus.27639 |
Ejemplares similares
-
The Role of Lofexidine in Management of Opioid Withdrawal
por: Pergolizzi, Joseph V., et al.
Publicado: (2018) -
Lofexidine for Treating Opioid Withdrawal Syndrome in Palliative Care Patients
por: Nair, Abhijit S
Publicado: (2018) -
Lofexidine for acute opioid withdrawal: A clinical case series
por: Renfro, Mandy L., et al.
Publicado: (2020) -
Safety and Efficacy of Lofexidine for Medically Managed Opioid Withdrawal: A Randomized Controlled Clinical Trial
por: Fishman, Marc, et al.
Publicado: (2019) -
Efficacy of lofexidine for mitigating opioid withdrawal symptoms: results from two randomized, placebo-controlled trials
por: Alam, Danesh, et al.
Publicado: (2020)